Patent 11110081
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Active provider: Google · gemini-2.5-flash
No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.
Cases on file (5)
Group view →Specific litigation cases in our database that name US patent 11110081. The free-form analysis below may also discuss cases beyond this list.
- Veloxis Pharmaceuticals AS v. Zydus Cadila et al.filed Apr 23, 20261:26-cv-00467Delaware District CourtOpen
Defendants: Zydus Cadila and Zydus Lifesciences Ltd
Other patents asserted: 11419823, 10864199, 8685998, 8664239, 11123331, 12403095, 10166190, 12083103, 9549918
The accused products are the 0.75 mg, 1 mg, and 4 mg extended-release tacrolimus tablets sold under the brand name ENVARSUS XR.
- Veloxis Pharmaceuticals, Inc. v. Glenmark Pharmaceuticals Inc., USAfiled Apr 14, 20251:25-cv-00458Delaware District CourtOpen
Defendants: Glenmark Pharmaceuticals Inc., USA
- Veloxis Pharmaceuticals AS v. Alkem Laboratories Ltd.filed Jul 3, 20241:24-cv-00784Delaware District CourtOpen
Defendants: Alkem Laboratories Ltd.
- 1:24-cv-00726Delaware District CourtOpen
Defendants: Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
- Veloxis Pharmaceuticals AS v. Intas Pharmaceuticals Ltd. et al.filed Jul 7, 20221:22-cv-00909Delaware District Courtterminated Jan 24, 2024judgment
Defendants: Intas Pharmaceuticals Ltd. and Accord Healthcare Inc.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
The following is a list of known litigation involving US patent 11110081, based on the provided information:
1. Veloxis Pharmaceuticals AS v. Intas Pharmaceuticals Ltd., Accord Healthcare Inc.
- Jurisdiction: Delaware District Court
- Case Number: 1:22-cv-00909
- Filing Date: 2022-07-07
- Outcome/Current Status: Closed on January 24, 2024. The case involved patent infringement concerning tacrolimus drug products. A consent judgment resulted in a permanent injunction for Veloxis Pharmaceuticals, Inc. US Patent 11110081 was among the patents-in-suit.
2. Veloxis Pharmaceuticals AS v. Zydus Lifesciences Ltd., Zydus Cadila
- Jurisdiction: Delaware District Court
- Case Number: 1:26-cv-00467
- Filing Date: 2026-04-23
- Outcome/Current Status: Open. This is an infringement case related to medical products.
3. Veloxis Pharmaceuticals AS v. Alkem Laboratories Ltd.
- Jurisdiction: Delaware District Court
- Case Number: 1:24-cv-00784
- Filing Date: 2024-07-03
- Outcome/Current Status: Open. This is an infringement case. Alkem Laboratories Ltd. admitted sending a Notice of Paragraph IV Certification regarding its ANDA for tacrolimus extended-release tablets, citing US Patent 11110081 among others.
4. Veloxis Pharmaceuticals, Inc. v. Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
- Jurisdiction: Delaware District Court
- Case Number: 1:24-cv-00726
- Filing Date: 2024-06-19
- Outcome/Current Status: Open. Veloxis Pharmaceuticals, Inc. filed this action asserting several patents, including US Patent 11110081. The thirty-month stay deadline for this case is November 9, 2026.
5. Veloxis Pharmaceuticals, Inc. v. Glenmark Pharmaceuticals Inc., USA
- Jurisdiction: Delaware District Court
- Case Number: 1:25-cv-00458
- Filing Date: 2025-04-14
- Outcome/Current Status: Open. This case asserts infringement of US Patent 11110081, among others, relating to Glenmark's ANDA for tacrolimus extended-release tablets. A stipulation and order regarding a stay was filed on February 2, 2026.
Generated 6/1/2026, 12:47:13 AM